ClinConnect ClinConnect Logo
Search / Trial NCT02164955

A Post Authorisation Registry of IMNOVID (Pomalidomide) for Patients With Relapsed and Refractory Multiple Myeloma.

Launched by CELGENE · Jun 13, 2014

Trial Information

Current as of April 29, 2025

Completed

Keywords

Pomalidomide Multiple Myeloma Relapsed, Refractory Observational Imnovid Registry Post Approval Safety

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Understand and voluntarily sign an informed consent form, if applicable, and have never been previously treated with pomalidomide before their inclusion in the Registry.
  • Patients with symptomatic, measurable relapsed and refractory multiple myeloma who have received at least two prior treatment regimens, including both bortezomib and lenalidomide and have demonstrated disease progression on the last therapy and are commencing a pomalidomide based treatment.
  • Exclusion Criteria:
  • Refusal to participate in the Registry or currently participating in the treatment phase of an interventional clinical trial.
  • Pregnancy.
  • Women of childbearing potential, unless all the conditions of the pregnancy prevention program are met.
  • Male patients unable to follow or comply with the required contraceptive measures.
  • Hypersensitivity to the active substance or to any of the excipients.

About Celgene

Celgene, now a part of Bristol Myers Squibb, is a global biopharmaceutical company dedicated to advancing innovative therapies for patients with cancer and other serious diseases. With a strong emphasis on research and development, Celgene focuses on discovering and delivering transformative medicines that address unmet medical needs. The company is committed to enhancing patient outcomes through rigorous clinical trials, cutting-edge science, and collaboration with healthcare professionals, ultimately striving to improve the quality of life for patients worldwide.

Locations

Truro, , United Kingdom

Oviedo, Asturias, Spain

Bologna, , Italy

Genova, , Italy

Minden, , Germany

Edegem, , Belgium

Lulea, , Sweden

Barcelona, , Spain

Reading, , United Kingdom

Mutlangen, , Germany

Ravensburg, , Germany

Oviedo, , Spain

Ottignies, , Belgium

Basingstoke, , United Kingdom

Dorchester, , United Kingdom

Cottbus, , Germany

Catania, , Italy

Slough, , United Kingdom

Palermo, , Italy

Salerno, , Italy

Liverpool, , United Kingdom

Worcester, Worcestershire, United Kingdom

Bruxelles, Avenue Hippocrate 10, Belgium

Antwerpen, Lindendreef 1, Belgium

Sint Niklaas, Lodewijk De Meesterstraat 5, Belgium

Verviers, Rue Du Parc 29, Belgium

La Louviere, Rue Ferrer 159, Belgium

Arlon, , Belgium

Liege, , Belgium

Odense, Kloevervanget 10, Denmark

Midtjylland, Noerrebrogade 44, Denmark

Vejle, , Denmark

Koln Kalk, Buchforststr 14, Germany

Berlin, Chariteplatz 1, Germany

Potsdam, Charlotteustr 72, Germany

Traunstein, Cuno Niggl Strate 3, Germany

Aschaffenburg, Elisenstr.26, Germany

Essen, Hufelandstraße 55, Germany

Schwabisch Hall, Innere Medizin Iii, Germany

Delitzsch, Ludwig Jahn Str. 4, Germany

Muenchen, Marchioninistr. 15, Germany

Karlsruhe, Medizinische Klinik Iii, Germany

Kronach, Niederbronner Stabe 2, Germany

Minden, Rintelner Strae 85, Germany

Berlin, Schwanebecker Chaussee 50, Germany

Flensburg, Waldstr. 17, Germany

Aachen, Weberstr. 8, Germany

Hamm, Werler Str. 110, Germany

Frankfurt, , Germany

Hamburg, , Germany

Hamburg, , Germany

Leipzig, , Germany

Minden, , Germany

Moers, , Germany

Mutlangen, , Germany

San Giovanni Rotondo, Fg, Italy

Firenze, Florence, Italy

Brescia, Lombardy, Italy

Napoli, Naples, Italy

Roma, Rome, Italy

Padova, Veneto, Italy

Bari, , Italy

Bergamo, , Italy

Brescia, , Italy

Cagliari, , Italy

Milano, , Italy

Milan, , Italy

Pisa, , Italy

Reggio Calabria, , Italy

Reggio Emilia, , Italy

Roma, , Italy

Torrette Di Ancona, , Italy

Treviso, , Italy

Turin, , Italy

Udine, , Italy

Alesund, , Norway

Bergen, , Norway

Drammen, , Norway

Fredrikstad, , Norway

Marbella, Autovia A 7, Km 187, Spain

Cordoba, Avda Menendez Pidal S/N, Spain

Sevilla, Avda. Bellavista, S/N, Spain

Cadiz, Avenida Ana De Viya, 21, Spain

Jaen, Avenida Ejercito Espanol 10, Spain

Caceres, Avenida Pablo Naranjo Porras, Spain

Valladolid, Avenida Ramon Y Cajal 3, Spain

Madrid, C/ Diego De León 62, 3a Planta, Spain

Lugo, C/ Doctor Severo Ochoa S/N, Spain

Palma De Mallorca, Calle Andrea Doria 55, Spain

Cartagena (Murcia), Calle Mezquita, Spain

Valencia, Calle San Clemente, 12, Spain

Elche, Cami De L´Almassera 11, Spain

Gijon, Camino De Los Prados, Spain

Tenerife, Carretera Del Rosario, 145, Spain

Palma De Mallorca, Ctra. Manacor, Km. 4, Spain

Alava, Jose Achotegui, Spain

Barcelona, L´Hospitalet De Llobregat, Spain

Barcelona, Passeig De La Vall D'hebron 119 129, Spain

Orihuela (Alicante), S/N San Bartolome, Spain

Malaga, Servicio De Oncologia, Spain

Umea, , Sweden

Wakefield, Aberford Road, United Kingdom

Doncaster, Armthorpe Road, United Kingdom

Northampton, Cliftonville, United Kingdom

County Durham, Darlington Memorial Hospital, United Kingdom

Broomfield,Chelmsford, Essex, United Kingdom

Aberdeen, Foresterhill Road, United Kingdom

Newcastle Upon Tyne, Freeman Hospital, United Kingdom

Lincoln, Greetwell Road, United Kingdom

Maidstone, Kent, United Kingdom

Blackpool, Lancashire, United Kingdom

Huddersfield, Lindley, United Kingdom

Worthing, Lyndhurst Road, United Kingdom

Airdrie, Monkscourt Avenue, United Kingdom

Bristol, Southmead Road, United Kingdom

Sunderland, Sunderland Royal Hospital, United Kingdom

Colchester, Turner Road, United Kingdom

Cardiff, Vale Of Glamorgan, United Kingdom

Harrow, Watford Road, United Kingdom

Swansea, West Glamorgan, United Kingdom

Carshalton, Wrythe Lane, United Kingdom

Bath, , United Kingdom

Oxford, , United Kingdom

Tyne And Wear, , United Kingdom

Patients applied

0 patients applied

Trial Officials

Bristol-Myers Squibb

Study Director

Bristol-Myers Squibb

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials